JP2021526829A5 - - Google Patents

Info

Publication number
JP2021526829A5
JP2021526829A5 JP2020568998A JP2020568998A JP2021526829A5 JP 2021526829 A5 JP2021526829 A5 JP 2021526829A5 JP 2020568998 A JP2020568998 A JP 2020568998A JP 2020568998 A JP2020568998 A JP 2020568998A JP 2021526829 A5 JP2021526829 A5 JP 2021526829A5
Authority
JP
Japan
Prior art keywords
aav
raav particles
feed composition
concentration
anion exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020568998A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526829A (ja
JP7385603B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/037013 external-priority patent/WO2019241535A2/en
Publication of JP2021526829A publication Critical patent/JP2021526829A/ja
Publication of JP2021526829A5 publication Critical patent/JP2021526829A5/ja
Application granted granted Critical
Publication of JP7385603B2 publication Critical patent/JP7385603B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020568998A 2018-06-14 2019-06-13 組換えaav生成のためのアニオン交換クロマトグラフィー Active JP7385603B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862684835P 2018-06-14 2018-06-14
US62/684,835 2018-06-14
PCT/US2019/037013 WO2019241535A2 (en) 2018-06-14 2019-06-13 Anion exchange chromatography for recombinant aav production

Publications (3)

Publication Number Publication Date
JP2021526829A JP2021526829A (ja) 2021-10-11
JP2021526829A5 true JP2021526829A5 (enExample) 2022-06-20
JP7385603B2 JP7385603B2 (ja) 2023-11-22

Family

ID=67513723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020568998A Active JP7385603B2 (ja) 2018-06-14 2019-06-13 組換えaav生成のためのアニオン交換クロマトグラフィー

Country Status (9)

Country Link
US (2) US12070702B2 (enExample)
EP (1) EP3807405A2 (enExample)
JP (1) JP7385603B2 (enExample)
KR (1) KR102930150B1 (enExample)
CN (1) CN112469822A (enExample)
AU (1) AU2019285186B2 (enExample)
CA (1) CA3102817A1 (enExample)
IL (2) IL319002A (enExample)
WO (1) WO2019241535A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11028372B2 (en) 2015-12-11 2021-06-08 The Trustees Of The University Of Pennsylvania Scalable purification method for AAVRH10
EP3387138B1 (en) 2015-12-11 2022-01-26 The Trustees Of The University Of Pennsylvania Scalable purification method for aav9
ES2934848T3 (es) 2015-12-11 2023-02-27 Univ Pennsylvania Método de purificación escalable para AAV8
EP3833745A1 (en) 2018-08-10 2021-06-16 REGENXBIO Inc. Scalable method for recombinant aav production
FI3953483T3 (fi) 2019-04-11 2023-11-30 Regenxbio Inc Kokoekskluusiokromatografiamenetelmiä rekombinanttien adenoassosioituneiden viruskoostumusten karakterisoimiseksi
TW202332458A (zh) 2019-04-19 2023-08-16 美商銳進科斯生物股份有限公司 腺相關病毒載體調配物及方法
WO2021158915A1 (en) * 2020-02-06 2021-08-12 Precision Biosciences, Inc. Recombinant adeno-associated virus compositions and methods for producing and using the same
CA3190596A1 (en) * 2020-08-07 2022-02-10 Janssen Biotech, Inc. Formulations for highly purified viral particles
US20230302381A1 (en) * 2020-08-18 2023-09-28 Sartorius Bia Separations D.O.O. Metal-affinity extraction of host cell dna
AU2021356684A1 (en) 2020-10-09 2023-05-11 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
WO2022082109A1 (en) 2020-10-18 2022-04-21 The Trustees Of The University Of Pennsylvania Improved adeno-associated virus (aav) vector and uses therefor
JP2023550581A (ja) 2020-10-29 2023-12-04 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Aavカプシド及びそれを含有する組成物
AU2021375404A1 (en) * 2020-11-03 2023-06-08 Pfizer Inc. Methods for purification of aav vectors by anion exchange chromatography
EP4263841A1 (en) 2020-12-16 2023-10-25 REGENXBIO Inc. Method of producing a recombinant adeno-associated virus particle
JP2024503895A (ja) 2021-01-21 2024-01-29 リジェネクスバイオ インコーポレイテッド 組換えポリペプチド及びウイルスの生成の改善
US20240084268A1 (en) * 2021-01-21 2024-03-14 Asklepios Biopharmaceutical, Inc. Method for purifying recombinant viral particles
JP7683230B2 (ja) * 2021-01-27 2025-05-27 東ソー株式会社 アデノ随伴ウイルスの精製方法
EP4299751A4 (en) * 2021-03-09 2025-08-13 Japan Chem Res METHOD FOR PRODUCING A RECOMBINANT AAV9 VIRION
WO2023060113A1 (en) 2021-10-05 2023-04-13 Regenxbio Inc. Compositions and methods for recombinant aav production
CN118202060A (zh) 2021-10-05 2024-06-14 再生生物股份有限公司 用于重组aav生产的组合物和方法
US20240408157A1 (en) 2021-12-02 2024-12-12 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
CN114317464B (zh) * 2021-12-27 2023-07-04 武汉汇研生物科技股份有限公司 腺相关病毒rAAV9的分离纯化方法
US20250213727A1 (en) 2022-03-25 2025-07-03 Regenxbio Inc. Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy
US20230303983A1 (en) * 2022-03-28 2023-09-28 President And Fellows Of Harvard College High efficiency purification of divergent aav serotypes using aavx affinity chromatography
WO2023239627A2 (en) 2022-06-08 2023-12-14 Regenxbio Inc. Methods for recombinant aav production
US20260021205A1 (en) 2022-07-15 2026-01-22 The Trustees Of The University Of Pennsylvania Recombinant aav having aav clade d and clade e capsids and compositions containing same
WO2024038365A1 (en) * 2022-08-16 2024-02-22 Pfizer Inc. Methods for purification of aav vectors by anion exchange chromatography
WO2024211780A1 (en) 2023-04-07 2024-10-10 Regenxbio Inc. Compositions and methods for recombinant aav production
WO2024233529A2 (en) 2023-05-07 2024-11-14 Regenxbio Inc. Compositions and methods for recombinant aav production
WO2024242150A1 (ja) * 2023-05-23 2024-11-28 東ソー株式会社 改変された組換えアデノ随伴ウイルス(aav)結合性タンパク質およびaavの精製方法
KR20260019521A (ko) * 2023-05-25 2026-02-10 주노 쎄러퓨티크스 인코퍼레이티드 Aav 정제 방법
WO2024263705A2 (en) * 2023-06-20 2024-12-26 Regeneron Pharmaceuticals, Inc. Methods for purifying filled adeno-associated virus capsids
WO2025090962A1 (en) 2023-10-25 2025-05-01 Regenxbio Inc. Compositions and methods for recombinant aav production
TW202540433A (zh) * 2023-11-21 2025-10-16 美商再生元醫藥公司 藉由活體外接合產生共價表面修飾之腺相關病毒及共價表面修飾的腺相關病毒之純化
EP4606892A1 (en) * 2024-02-23 2025-08-27 Merck Patent GmbH Methods for the production of viral particles
WO2025226558A1 (en) * 2024-04-22 2025-10-30 Ultragenyx Pharmaceutical Inc. Multi-step filtration and clarification methods for recombinant adeno-associated virus purification
WO2025228321A1 (en) * 2024-04-29 2025-11-06 Skyline Therapeutics (Shanghai) Co., Ltd. METHOD OF SEPARATING RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) PARTICLES

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
CA2379166C (en) 1999-08-09 2013-03-26 Targeted Genetics Corporation Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
JP2003518380A (ja) * 1999-12-29 2003-06-10 ジェンザイム・コーポレイション 核酸および他の細胞性汚染混入物質からウイルスベクターを分離するための濾過助剤の使用方法
WO2002000337A1 (en) 2000-06-27 2002-01-03 Bia Separations D.O.O. A chromatography material and a process of manufacturing that material
US6593123B1 (en) 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
MX359371B (es) 2001-11-13 2018-09-25 Univ Pennsylvania Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
PT1453547T (pt) 2001-12-17 2016-12-28 Univ Pennsylvania Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
US7261544B2 (en) 2003-05-21 2007-08-28 Genzyme Corporation Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
EP2345731B1 (en) 2003-09-30 2015-10-21 The Trustees of the University of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
US7183969B2 (en) 2004-12-22 2007-02-27 Raytheon Company System and technique for calibrating radar arrays
ES2525067T3 (es) 2005-04-07 2014-12-17 The Trustees Of The University Of Pennsylvania Método de incremento de la función de un vector de AAV
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
ES2751999T3 (es) 2008-01-29 2020-04-02 Applied Genetic Tech Corporation Producción recombinante de virus adeno-asociados usando células BHK en suspensión
JP2011512156A (ja) 2008-02-19 2011-04-21 アムステルダム モレキュラー セラピューティクス ビー.ブイ. 昆虫細胞におけるパルボウイルスrep及びcapタンパク質の発現の最適化
EP2425000B1 (en) 2009-04-30 2019-02-20 The Trustees Of The University Of Pennsylvania Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
WO2012057363A1 (ja) 2010-10-27 2012-05-03 学校法人自治医科大学 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン
WO2012109570A1 (en) 2011-02-10 2012-08-16 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
CN105755044A (zh) 2011-04-22 2016-07-13 加利福尼亚大学董事会 具有变异衣壳的腺相关病毒病毒体及其使用方法
ES2857773T5 (es) 2011-08-24 2024-06-04 Univ Leland Stanford Junior Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
WO2013170078A1 (en) 2012-05-09 2013-11-14 Oregon Health & Science University Adeno associated virus plasmids and vectors
CA2905952A1 (en) 2013-03-13 2014-10-02 The Children's Hospital Of Philadelphia Adeno-associated virus vectors and methods of use thereof
MX388221B (es) 2013-04-20 2025-03-19 Res Institute At Nationwide Children´S Hospital ADMINISTRACIÓN DE VIRUS ADENO-ASOCIADO RECOMBINANTE DE CONSTRUCCIONES DE POLINUCLÉOTIDOS U7snRNA DIRIGIDA AL EXÓN 2.
IL297919A (en) 2013-07-22 2023-01-01 Childrens Hospital Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
ES2739288T3 (es) 2013-09-13 2020-01-30 California Inst Of Techn Recuperación selectiva
CN106232618A (zh) 2013-10-11 2016-12-14 马萨诸塞眼科耳科诊所 预测祖先病毒序列的方法及其用途
WO2015164757A1 (en) 2014-04-25 2015-10-29 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
EP3151866B1 (en) 2014-06-09 2023-03-08 Voyager Therapeutics, Inc. Chimeric capsids
AU2015320694B2 (en) 2014-09-24 2021-11-11 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP6665466B2 (ja) 2015-09-26 2020-03-13 日亜化学工業株式会社 半導体発光素子及びその製造方法
WO2017070491A1 (en) 2015-10-23 2017-04-27 Applied Genetic Technologies Corporation Ophthalmic formulations
ES2934848T3 (es) * 2015-12-11 2023-02-27 Univ Pennsylvania Método de purificación escalable para AAV8
US11028372B2 (en) 2015-12-11 2021-06-08 The Trustees Of The University Of Pennsylvania Scalable purification method for AAVRH10
WO2017100674A1 (en) * 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav1
EP3387138B1 (en) * 2015-12-11 2022-01-26 The Trustees Of The University Of Pennsylvania Scalable purification method for aav9
WO2017160704A1 (en) * 2016-03-14 2017-09-21 Perumala Corporation Photovoltaic systems with intermittent and continuous recycling of light
WO2019178495A1 (en) 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses

Similar Documents

Publication Publication Date Title
JP2021526829A5 (enExample)
US12351832B2 (en) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
US20220364111A1 (en) Methods for producing preparations of recombinant aav virions substantially free of empty capsids
EP3256574B1 (en) Recombinant adeno-associated virus particle purification comprising an affinity purification step
JP2018510648A5 (enExample)
JP2018522529A5 (enExample)
JP2021514659A5 (enExample)
JP2017509632A5 (enExample)
JP2024525142A5 (enExample)
JP2024511409A5 (enExample)
CA2975569C (en) Recombinant adeno-associated virus particle purification comprising an affinity purification step
RU2025127724A (ru) Молекула нуклеиновой кислоты, содержащая асимметрично модифицированный ITR для повышения уровня экспрессии встроенного гена, и ее применение
CN119816351A (zh) 用于分离完整的aav颗粒和空aav颗粒的方法
HK1227436A (en) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
HK1227436A1 (en) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
NZ761655A (en) Cellular models of and therapies for ocular diseases
HK1227435A (en) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
HK1227435A1 (en) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
NZ761655B2 (en) Cellular models of and therapies for ocular diseases